References
- Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syn-drome (AIDS) and AIDS related complex. Am J Med 1987; 82: 900–6.
- Simberkoff MS, Leaf HL. Bacterial infections in patients with HIV infection. In: Wormer EP, editor. AIDS and Other Manifestations of HIV infection, 2nd ed. New York: Raven Press. 1992: 269-75.
- Omenaca C, Turett G, Yarrish R et al. Bacteremia in HIV-infected patients: short-term predictors of mortality. J Acquir Immune Defic Syndr 1999; 22: 155–60.
- Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian University hospital. J Infect 1995; 31: 123–31.
- Noskin GA, Glassroth J. Bacterial pneumonia associated with HIV-1 infection. Clin Chest Med 1996; 17: 713–23.
- Tumbarello M, Tacconelli E, de Gaetano K et al. Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognostic indicators. J Acquir Immune Defic Syndr 1998; 18: 39–45.
- Schonwald S, Begovac J, Skerk V. Urinary tract infec-tions in HIV disease. Int J Antimicrob Agents 1999; 11: 309–11.
- Tumbarello M, Tacconelli E, de Gaetano Donati K et al. Nosocomial bloodstream infections in HIV-infected patients: attributable mortality and excess of hospital stay. J Acquir Immune Defic Syndr 1998; 19: 490–6.
- Zurlo JJ, Lane HC. Other bacterial infections. In: De Vita VT, Hellman S, Rosenberg SA, eds. AIDS: aetiology, diagnosis, treatment and prevention, 4th ed. Philadelphia-New York: Lippincott-Raven 1997: 259-65.
- Deeks SG, Smith M, Holodniy, Kahn JO. HIV-1 pro-tease inhibitors. A review for clinicians. JAMA 1997; 277: 145–53.
- Jacobson MA, French M. Altered natural history of AIDS-related opportunistic infections in the era of potent com-bination of antiretroviral therapy. AIDS 1998; 12: S157-63.
- Paul S, Gilbert HM, Ziecheck W, Jacobs J, Sepkowitz KA. The impact of potent antiretroviral therapy on the char-acteristics of hospitalised patients with HIV infection. AIDS 1999; 13: 415–8.
- Garner JS, Jarvis WR, Emoti TG. CDC definition for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
- Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalised adults. Chest 1991; 100: 1619–36.
- Mouton Y, Alfandari S, Valette F et al. Impact of pro-tease inhibitors on AIDS-defining events and hospitalisations in 10 French AIDS reference centres. AIDS 1997; 12: F101–5.
- Ledergerber B, Egger M, Erard V, et al. AIDS-related opportunistic illnesses occurring after initiation of potent anti-retroviral therapy: the Swiss HIV Cohort Study. JAMA 1999; 282: 2220–6.
- Tacconelli E, Tumbarello M, de Gaetano K, Cauda R, Ortona L. Highly active antiretroviral therapy decreases the incidence of bacteraemia in Human Immunodeficiency Virus-infected individuals. Clin Infect Dis 1998; 27: 901–2.
- Tumbarello M, Tacconelli E, de Gaetano Donati K, Cauda R. HIV-associated bacterial pneumonia in the era of Highly Active Antiretroviral Therapy. J Acquir Immune Def Syndr 1999; 20: 208–9.
- Mertins SD, Cauda R. The role of polymorphonuclear leukocytes in infection by retrovirus with emphasis on the human immunodeficiency virus. Viral Immunol 1990; 3: 173–7.
- Tumbarello M, Tacconelli E, de Gaetano Donati K et al. Nosocomial bacterial pneumonia in human immunodefi-ciency virus infected subjects: incidence, risk factors and out-come. Eur Respir J 2001; 17: 636–40.